Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
Show notes
(00:32)
Could you please provide us a little information about your background?
(01:46)
Could you please give the audience a brief overview of this assay?
(03:45)
Which patients should have this testing and when should it be performed?
(06:39)
How are the results used in patient care?
(08:51)
What alternative test options are available and how do they compare to our test?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Closing a Diagnostic Gap for Chronic Diarrhea
Answers from the Lab
Unlock the Full Potential of Research Data
Answers from the Lab
A New Mindset for Leading Through Change
Answers from the Lab
Key Components of Innovation Success
Answers from the Lab